Glaxosmithkline Uk competitive analysis

Explore patent oppositions filed by Glaxosmithkline Uk against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 2, 2026
Patent NumberTitleApplicantOpposition Date
Medicaments For Increasing Endogenous Erythropoietine (Epo)FIBROGENFeb 19, 2020
Use Of Hif Alpha Stabilizers For Enhancing ErythropoiesisFIBROGENJun 26, 2019

Latest PTAB cases involving Glaxosmithkline Uk

Discover the latest PTAB cases involving Glaxosmithkline Uk, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Glaxosmithkline Uk with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 2, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
GLAXOSMITHKLINE2912063
FIBROGEN117 - 6